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Abstract.  Cell adhesion is a process which is initiated 
by the attachment of ceils to specific sites in adhesive 
matrix proteins via cell surface receptors of the inte- 
grin family. This is followed by a reorganization  of cy- 
toskeletal dements which results in cell spreading and 
the formation of focal adhesion plaques. We have ex- 
amined the effects of a class of small galactosamino- 
glycan-containing proteoglycans on the various stages 
of cell adhesion to fibronectin-coated substrates.  Our 
results indicate that dermatan  sulfate proteoglycans 
(DSPGs) derived from cartilage,  as well as other re- 
lated small proteoglycans, inhibit the initial attachment 
of CHO cells and rat embryo fibroblasts to substrates 
composed of the  105-kD cell-binding fibronectin frag- 
ment,  but do not affect cell attachment to intact fibro- 
nectin.  Although this effect involves binding of DSPGs 
to the substrate via the protein core, the intact proteo- 
glycan is necessary for the observed activity. Isolated 
core proteins are inactive.  The structural composition 
of the galactosaminoglycan chain does not appear to 
be functionally significant since both chondroitin sul- 
fate and various dermatan sulfate proteoglycans of this 
family inhibit cell attachment to the fibronectin frag- 
ment.  Neither the percentage of cells spread nor the 
mean area of spread cells adhering to substrates of 
intact fibronectin was significantly affected by the 
DSPGs.  However, significantly fewer cells formed fo- 
cal adhesions in the presence of DSPGs as compared 
with untreated control ceils.  These results suggest that 
the binding of small galactosaminoglycan-containing 
proteoglycans to a fibronectin substrate may affect sev- 
eral stages in the cell adhesion process. 
HESION of cells to supporting substrates is of funda- 
mental  importance  for  normal  cell  behavior  and 
has been extensively  studied at the molecular level 
during  the past decade. It is now known that attachment of 
cells to a substrate is specifically  promoted by a family of 
adhesive matrix proteins (including fibronectin,  laminin,  vi- 
tronectin,  fibrinogen,  and some collagen types). Specific do- 
mains in these proteins,  which often include the amino acid 
sequence RGD, are recognized by corresponding cell surface 
receptors.  The different  receptors are structurally  related 
and are, therefore,  grouped together as a family of receptor 
proteins referred to as integrins  (1, 4, 21, 29). 
The initial attachment of a cell to a substrate composed of 
an  adhesive  matrix  is  followed  by a  reorganization  of 
cytoskeletal components resulting in a flattening and spread- 
ing  of the  cell  body.  Subsequently,  specialized  adhesive 
structures  (i.e.,  focal  adhesions)  are  often  formed  (for 
reviews  see 5,  37).  In vivo,  the adhesive  process must be 
carefully regulated, and in certain situations, i.e., during mi- 
tosis and migration,  the cells must dissolve and reassemble 
the adhesive structures in an orderly fashion. The molecular 
mechanisms involved in the later stages of the cell adhesion 
process and in regulation of cell adhesion are poorly under- 
stood. Previous studies have shown that certain extracellular 
matrix components such as thrombospondin (25),  tenascin 
(26) and SPARC (26, 30) may regulate cell adhesion by inter- 
fering with some of the later stages in the adhesive process. 
Some proteoglycans  have also been shown to inhibit the 
early stages ofceU adhesion, i.e., cell attachment.  For exam- 
ple, a large chondroitin  sulfate proteoglycan (CSPG) purified 
from a rat yolk sac tumor (3) and a mixture of dermatan sul- 
fate  proteoglycans  (DSPGs)  ~ (22)  isolated  from cartilage 
were shown to inhibit the attachment of ceils to fibronectin- 
coated substrates. In these cases, the proteoglycans were pre- 
sumed to exert their inhibitory effects by binding  via their 
polysaccharide chains to glycosaminoglycan binding sites in 
the fibronectin molecule.  It was proposed that the bulky pro- 
teoglycans sterically interfered with the interactions between 
the cell-anchored  integrins  and the corresponding binding 
site in the substrate.  Furthermore,  cartilage  was found  to 
contain two species of DSPG (DSPG I or "biglycan" and 
1. Abbreviations used in this paper: DSPG, dermatan sulfate proteoglycan; 
REF, rat embryo fibroblast. 
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core proteins  (28).  One of these  DSPGs,  DSPG  II,  was 
shown to bind to fibronectin through protein-protein inter- 
actions (32) and also to a cell surface endocytosis receptor 
(12, 13). These findings prompted us to reexamine the effects 
of various  proteoglycans  on  the  different  stages  of cell 
adhesion. 
Materials and Methods 
Materials 
Dermatan sulfate proteoglycan I  Cbiglycan," DSPG I), dermatan sulfate 
proteoglycan II ("decorin," DSPG II), each containing 40% iduronic acid, 
and the large CSPG were isolated from bovine articular cartilage (6, 28, 34). 
PG-S1, containing 100% glucuronic acid, from nasal cartilage (15), PG-S2, 
containing  73%  iduronic  acid,  from  bovine  flexor  tendon  (35),  and 
fibromodulin, a small keratan sulfate proteoglycan, from bovine articular 
cartilage (16) were generously provided by Dr.  Dick Heinegard (Depart- 
ment of Medical and Physiological Chemistry, Lund  University, Lurid, 
Sweden). The scleral DSPG II (7) containing 50-60% iduronic acid, was 
provided by Dr. Anders Malmstrom (Department of Physiological Chemis- 
try, Land University, Lund, Sweden). Ham's F-12 Growth Medium (F-12), 
DME, trypsin-EDTA, and glutamine were purchased from Gibco Labora- 
tories (Grand Island,  NY).  FBS was obtained from Flow Laboratories 
(McLean, VA) or from Hyclone Laboratories (Logan, UT). Tissue culture 
flasks  were acquired from NUNC, Irvine Scientific (Santa Aria, CA) or 
from Sumilon, Vanguard International (Neptune, NJ). [3H]Thymidine (196 
mCi/mg),  Na125I (16.9  mCi/mg)  and aqueous  counting scintilfant were 
purchased from Amersham Corporation (Arlington Heights, IL).  Glass 
coverslips, Falcon 3072  microtiter tissue culture plates, Falcon 3047 24- 
well  tissue  culture  plates,  and  Tween  20  were  obtained  from  Fisher 
Scientific Co. (Atlanta, GA). Immulon 2 Removawells were purchased from 
Dynatech Laboratories Inc. (Chantilly, VA). All other reagents used were 
procured from Sigma Chemical Co.  (St.  Louis, MO). 
Cell Culture 
CHO cells (CHO-KI ATCC# CCL 61) were provided by Dr. Jeffrey D. Esko 
(Department of Biochemistry, University of Alabama at Birmingham) and 
rat embryo fibroblasts (REF) were provided by Dr. Anne Woods (Depart- 
ment of Cell Biology, University of Alabama at Birmingham). CHO cells 
were maintained in F-12 growth medium, and REF cells were maintained 
in DME supplemented with 2 mM glutamine. All growth media were sup- 
plemented with 10 % FBS (vol/vol) unless otherwise stated. Cells were rou- 
tinely maintained in monolayer culture and detached with trypsin (CHO 
ceils) or trypsin-EDTA (REF) for sequential passage every 4-7 d. 
Preparation of Substrates 
Human  fibronectin was purified from outdated plasma  (American Red 
Cross, Birmingham, AL) according to the method of Engvall and Ruoslahti 
(10) as modified by Miekka et al.  (24)  or purchased from the New York 
Blood Center Inc. (New York). The 105-kD fibronectin "cell-binding" pep- 
tide, generously provided by Dr. Staffan Johansson (University of Uppsala, 
Sweden), was generated by chymotrypsin digestion of intact fibronectin and 
was isolated and characterized as previously described (38). 24-well tissue 
culture plates (2.0 cm  2 surface area/well) or glass coverslips (1.2 cm  2 sur- 
face area/coverslip) were coated with human fibronectin (8/zg per well or 
4.52/zg per coverslip) or equimolar amounts of 105-kD fibronectin peptides 
(3.8/~g per well or 2.16/~g per coverslip). Microtiter wells (0.6 cm  2 surface 
area per well) were coated with 1.12/zg fibronectin or 0.53/~g of the 105-kD 
fibronectin fragment pr well by incubation at 40C for 12 h followed by a 
rinse with PBS. To block unoccupied protein binding sites, the coated wells 
were incubated with either 2%  BSA,  heat treated at 56~  for  1 h  and 
filtered, or with PBS containing 1% native BSA for 1 h at 4~  The sub- 
strates were then rinsed with PBS and the appropriate assay buffer. 
Cell Attachment Assay 
Cells (105) were seeded in 75-cm  2 tissue culture flasks and incubated for 
2-4 d. Cells, still in the log phase of growth, were labeled for 3 h before 
harvest by adding 2 #Ci of [3H]thymidine per ml culture medium. In all at- 
tachment assays cycloheximide (10 t~g/ml) was added to the culture medium 
2 h before harvest and included in all subsequent washing and assay buffers. 
At harvest, radiolabeled cells were detached by trypsin treatment, washed 
twice with 5 ml of FI2 containing 10% PBS (F12/PBS), and resuspended 
in  F12/PBS.  Cell  numbers  were  determined  with  a  Coulter  Counter 
(Coulter Electronics Inc., Hialech, FL) or a hemocytometer. 
Radiolabeled cells suspended in  F12/PBS  were  seeded in  substrate- 
coated 24-well tissue culture plates (60,000 cells per well) or in 96-well mi- 
crotiter plates (20,000  cells per well). In some experiments, the substrates 
were preincubated with 100/~g/ml  proteoglycans, isolated core proteins, or 
isolated glycosaminoglycan chains (see figure legends for more details). 
The cells were incubated at 37~  for the indicated periods of time and the 
percent of cells attached to the substrate was determined essentially as de- 
scribed by Couchman et al. (8).  Briefly,  unattached cells were collected, 
wells were washed three times with PBS, and the wash was combined with 
the unattached cells. Attached cells were solubilized by incubation with 1% 
SDS in PBS for 6-12 h at 37~  and collected. The wells were washed three 
times with PBS and the wash was combined with the solubilized cells. Ra- 
dioactivity in the two pools was determined and the percentage of cells at- 
tached was calculated assuming all the radioactivity was associated with the 
cells. Each value was the average of at least two determinations. 
DSPG Binding Assays 
Proteins were iodinated either using the chloramine-T method of Hunter 
(20) or using "Enzymobeads" (Bio-Rad Laboratories, Richmond, CA) in a 
modified lactoperoxidase reaction performed according to manufacturer's 
instructions. The labeled macromolecules were then separated from free io- 
dine by gel permeation chromatography on a PD-10 column (Pharmacia- 
LKB Biotechnology, Inc., Piscataway,  NJ). Iodinated DSPGs were diluted 
with PBS and 5  x  104 cpm (specific activity =  ~1  ￿  106 cpm/#g DSPG) 
of 125I-DSPG in 50-100 #1 were placed in substrate-coated wells and in- 
cubated at 37~  (see figure legends for more details). Unbound DSPGs 
were removed and the wells were rinsed with PBS containing 0.1% Tween 
20.  The radioactivity bound to substrate containing the adsorbed protein 
was determined by breaking off the washed individual wells of the Immulon 
2 removawell plates and placing them into gamma tubes before counting in 
an LKB gamma counter. 
Assays to determine dissociation constants on substrates composed of ei- 
ther fibronectin or the 105-kD fragment of  fibronectin were performed using 
125I-labeled intact DSPG II or isolated core protein from DSPG II and ana- 
lyzed as previously described (2). 
Cell Spreading and Focal  Adhesion Assays 
Cell spreading and focal adhesion formation were assayed as described by 
Woods et al. (38) and Murphy-Ullrich and Hook (25). Glass coverslips were 
coated with 4.25/zg human plasma fibronectin or 5 #g BSA in 100 t~l PBS 
and air dried overnight. Substrates were rehydrated, washed, and additional 
protein binding sites were blocked by incubation with 1% heat-denatured 
BSA. Coverslips were washed and then incubated for 1 h at room tempera- 
ture with 0.5 ml DME containing 100 #g/ml DSPG I or DSPG II in PBS. 
In some experiments, DSPGs were added at the time of seeding cells onto 
the  coverslips.  Cells  were  harvested  as  described above,  pelleted and 
resuspended in DME. ,'060,000 cells were added to each coverslip in a 24- 
well plate. Unless otherwise stated, cycloheximide  was maintained at a con- 
centration of 10/zg/ml throughout the experiment. Cells were allowed to 
attach and spread for 3 h at 37~  fixed with 3% warmed glutaraldehyde 
for 30 min, washed, and examined by phase and interference reflection mi- 
croscopy using a Nikon Optiphot microscope (Nikon Inc., Melville, NY). 
Spread cell area was measured using a digital planimeter system (Microplan 
II; Laboratory Computer Systems, Inc., Cambridge, MA). To quantify the 
percent of cells positive for focal adhesion formation, a minimum of 150 
cells per coverslip was examined by interference reflection microscopy. 
Cells were scored as positive if they had at least three plaques per cell. 
Spread cells were designated as those which were noncircular in shape and 
had cytoplasm visible by phase microscopy. 
Immunofluorescence Microscopy 
Immunofluorescence staining of vinculin and F-actin were performed ac- 
cording to procedures described by Murphy-Ullrich and Hook (25). Cells 
were treated as described above in the ceil spreading assays, and then fixed, 
permeabilized, and stained for vinculin with a  mAb to vinculin, (clone 
VIN-11-5,  Sigma Chemical Co.)  and for F-actin using NBD-phallicidin 
(Molecular Probes, Eugene, OR). 
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Figure 1.  Inhibition of cell attachment  to the  105-kD fibronectin 
fragment  by DSPGs. CHO cells (A and C) or REFs (B) were seeded 
on substrates composed of intact fibronectin or the  105-kD fibro- 
nectin fragment in the presence of increasing concentrations of ei- 
ther a mixture of both DSPG I and DSPG H (,4 and B) or purified 
DSPG I and DSPG II (C). Cells were labeled with [3H]thymidine 
and cell attachment assays were performed as indicated in Materi- 
als and Methods. The substrates composed of intact fibronectin and 
the  105-kD fibronectin fragment were preincubated  with varying 
concentrations  (0-100/zg/ml)  of the DSPG mixture or the individ- 
ual DSPG species for 1 h before the addition of cells. Cells were 
allowed to attach for 90 min and then unbound cells were removed, 
followed by three rinses in PBS. Bound cells were solubilized by 
incubation with 1% SDS in PBS for 6-12 h and removed. The per- 
centage of ceils attached was calculated assuming all radioactivity 
was associated with the cells. The results are expressed as the mean 
and ranges of determinations from at least two wells. (A and B) (-) 
percent cells attached to the intact fibronectin coated substrate; and 
(e) percent  cells attached  to the  105-kD fibronectin  fragment- 
coated surface.  (C) (.) percent cells attached  in the presence of 
DSPG II; and (o) percent cells attached in the presence of DSPG I. 
observed for CHO cells. The effect was not due to nonspe- 
cific charge  interactions  with the  glycosaminoglycan side 
chains, since the presence of heparin at molar concentrations 
similar to those of the DSPG did not effect the attachment 
of either cell type to substrates composed of intact fibronec- 
tin or its  105-kD fragment (data not shown). 
When purified preparations of DSPG I and DSPG II were 
examined separately for their effects on CHO cell attach- 
ment, both proteoglycan species effectively inhibited cell at- 
tachment to wells coated with the 105-kD fibronectin frag- 
ment (Fig.  1 C).  Under the conditions of the experiment, 
DSPG I seems to be only slightly more effective than DSPG 
II.  In contrast,  cell  attachment to  intact  fibronectin  was 
unaffected by the presence of the individual  proteoglycan 
species (data not shown). 
Since the DSPGs did not affect cell attachment to sub- 
strates composed of intact fibronectin, we examined whether 
DSPGs affected the later stages in the adhesion process of 
cells attached to fibronectin. Analysis of cell spreading re- 
vealed  that  neither  CHO  cells  nor  REFs  seeded  onto 
fibronectin substrates were significantly affected by preincu- 
bation of the substrates with either DSPG I or DSPG II. Both 
the area of spread cells and the percent of cells spread on 
fibronectin substrates preincubated with either DSPG I or 
DSPG II were comparable with cells spread on untreated 
fibronectin (Table I). 
In contrast,  the  ability  of cells  to  form focal adhesion 
plaques on composite substrates of fibronectin and DSPG 
was reduced as compared with cells seeded on fibronectin 
substrates (Table I). When examined by interference reflec- 
tion microscopy, we observed that 73 % of the ceils formed 
focal adhesions  on  fibronectin-coated  substrates,  whereas 
only 51  and 47 % of cells formed adhesion plaques on sub- 
strates composed of fibronectin preincubated with DSPG I 
or DSPG II, respectively. Cells spread on substrates contain- 
ing DSPG often had broad lameUae which lacked focal adhe- 
sion plaques (Fig. 2, a and d). These cells had fewer plaque- 
like clusters of vinculin (Fig. 2, b and e) as compared with 
control  cells  spread on  fibronectin  substrates  (Fig.  2  h). 
In focal adhesion negative cells spread on composite sub- 
strates of fibronectin and DSPG II (Fig. 2f), the density and 
Results 
Effects of DSPGs on Cell Adhesion to 
Fibronectin-Coated Substrates 
Attachment of CHO cells to a  substrate composed of the 
105-kD fibronectin fragment was inhibited by a mixture of 
DSPG I and DSPG II in a concentration dependent manner 
(Fig. 1 A). The number of CHO cells attaching to the coated 
substrate was reduced from 95 to <30%  in the presence of 
10/~g/ml of proteoglycan. At concentrations of proteoglycan 
>60/~g/ml,  the number of attached cells was comparable 
with  levels  seen with  a  nonadhesive  substrate,  e.g.,  BSA 
(•10-25%  cell  attachment).  In contrast,  the  presence  of 
DSPG did not affect the attachment of CHO cells to sub- 
strates coated with intact fibronectin (Fig.  1 A). Essentially 
identical results were seen in assays using REFs (Fig.  1 B) 
except  that  slightly  higher  concentrations  of DSPG  were 
needed to obtain the same degree of inhibition of attachment 
on the  105-kD fibronectin fragment-coated surface as that 
Table L  The Effect of  DSPGs on Cell Spreading and Focal 
Adhesion Formation 
Substrate 
Percent REFs  Cells spread  Spread  cell areaw 
positive for 
focal adhesions*  REF~  REF  CHO-K1 
BSA  0 
FN  73  •  4 
FN+DSPG  I  51  •  5 
FN + DSPG  II  47  •  6 
%  ~um  2  /~m  2 
0  170•  47  •  12 
94  2092  •  589  315  •  100 
95  2072  •  579  278  +  139 
93  2101  •  481  215  •  121 
The effect of DSPG I and DSPG H on cell spreading and focal adhesion forma- 
tion. Cell spreading and focal adhesion assays were performed as indicated in 
the Materials and Methods section.  Spread cell area was measured using a digi- 
tal planimeter system and the average spread cell area was calculated.  Cells 
were scored  as positive for focal adhesions if they had at least three plaques 
and spread cells were designated as those which were noncircular in shape and 
had cytoplasm visible by phase microscopy. 
* These are the results of four experiments in which 150 cells per treatment 
per experiment were counted. 
~: n  =  100 cells per treatment. 
w  n  --  50 cells per treatment. 
Bidanset et al. Dermatan Sulfate Proteoglycans and Cell Adhesion  1525 Figure 2. The effects of DSPG I and DSPG II on cell spreading and focal adhesion formation on substrates composed of intact fibronectin. 
REFs were seeded onto fibronectin substrates that had been preincubated with DSPG I (a, b, and c), DSPG I/(d, e, and f), or with DME 
as a control (g, h, and i) and allowed to attach and spread in the continued presence of proteoglycans for 3 h.  REFs were examined for 
focal adhesion formation by interference reflection microscopy (a, d,  and g).  Ceils were also fixed, permeabilized, and stained for the 
presence of vinculin using the mAb VIN-11-5 (b, e, and h) and F-actin using NBD-phallicidin (c, f, and i). Some cells spread on substrates 
preincubated with either DSPG I (a) or DSPG II (d) lack focal adhesion plaques and exhibit ruffling of the membranes. Numerous adhesion 
plaques are present in cells spread on fibronectin substrates (arrowheads, g). The clustering of vinculin into adhesion plaques is reduced 
in cells spread on composite DSPG-fibronectin substrates (b and e). The density and thickness of the actin-containing stress fibers are 
reduced in cells on substrates preincubated with DSPG II (f) as compared with control cells spread on fibronectin substrates (i) or on 
substrates preincubated with DSPG I (c).  Bars,  10 #m. 
thickness  of  the  F-actin-containing  microfilaments  were 
markedly  reduced  as  compared  with  cells  spread  on  sub- 
strates of untreated  fibronectin  (Fig.  2  i).  The cells spread 
on  substrates of fibronectin  and  DSPG  I  (Fig.  2  c),  which 
lacked focal adhesions by interference reflection microscopy 
and had reduced clustering of vinculin,  showed organization 
of F-actin into microfilaments which were only slightly thin- 
ner and  less dense  than  in unaffected  ceils. 
To examine if the observed inhibitory effects of cell attach- 
ment  to  the  105-kD  fibronectin  fragment  were  a  conse- 
quence  of an  interaction  between  the  DSPGs  and  cells or 
were a result of a binding of DSPGs to the substrate, the fol- 
lowing experiments were performed.  Cells (REFs or CHO 
cells) were preincubated with DSPG mixtures for 1 h.  The 
cells  were  washed  and  subsequently,  seeded  on  substrates 
composed  of  the  105-kD  fibronectin  fragment.  Alterna- 
tively, the substrates were preincubated with the DSPGs for 
1 h,  rinsed,  and  used  in  cell attachment  experiments.  The 
results of these experiments (Fig. 3) showed that the pretreat- 
ment of ceils with DSPG did not affect their attachment to 
the substrate. In contrast, preincubation of the substrate with 
the DSPGs resulted in an inhibition of both CHO (Fig.  3 A) 
and REF  (Fig.  3  B) cell attachment.  The inhibitory effects 
were  almost  as  pronounced  as  those  observed  when  the 
DSPGs  were  present  throughout  the  incubation  (Fig.  3). 
These data indicate that the inhibitory effect of DSPG on cell 
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attachment is due to an inter- 
action  between the DSPGs and 
the  fibronectin-coated  sub- 
strate.  Substrates  were coated 
with  the  105-kD  fibronectin 
fragment as indicated  in Ma- 
terials  and Methods. In treat- 
ment  1,  CHO  cells  (A)  and 
REF cells (B) were allowed to 
attach to the substrate without previous treatment.  In 2, the cells 
were preincubated with the DSPG mixture (I00/zg/ml) for 60 min 
followed by a wash, before seeding on the 105-kD fibronectin  frag- 
ment substrate.  In treatment 3, the substrates  were preincubated 
with the DSPG mixture for 60 min and washed before the seeding 
of the cells.  In 4, the substrates  were preincubated with the DSPG 
mixture for 60 rain before addition of cells and the attachment was 
allowed to proceed in the presence of the DSPGs. The results  are 
expressed as the means and ranges of determinations from at least 
three wells. 
attachment is caused by interaction(s) of DSPG with the sub- 
strate and not through DSPG-cell interactions. 
Binding of  DSPG to Intact Fibronectin and 
the 105-kD Fragment 
To examine the possibility that the DSPGs are actually bind- 
ing to the fibronectin substrate,  the proteoglycans were ~25I- 
labeled and ",,50,000 cpm of DSPG I or DSPG II were in- 
cubated  at  37~  in  microtiter  wells  coated  with  intact 
fibronectin, the 105-kD fibronectin fragment or BSA for var- 
ious time periods.  The wells were washed extensively and 
the  amount  of bound  t25I-labeled  ligand  quantifed.  Both 
DSPG I and DSPG II bound to all three substrates in a time- 
dependent manner which reached a plateau at *1 h (Fig. 4). 
The  relative  amount  of  ~2~I-labeled  DSPG  II  binding  to 
wells coated with intact fibronectin or the 105-kD fibronec- 
tin  fragment varied  somewhat but was consistently  higher 
than  that  bound  to  BSA  (Fig.  4  B).  When  t25I-labeled 
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Figure  4.  Binding  of iodinated  DSPG I  (.4)  and DSPG II  (B) to 
fibronectin substrates.  Fibronectin (e), the 105-kD fibronectin frag- 
ment (A), or BSA-coated  substrates  (m) were blocked with BSA 
for 60 min and incubated with 50,000 cpm (approximate  specific 
activity  =  1  x  l0  s cpm//~g  DSPG)  of 125I-labeled DSPG I  or 
DSPG II in a volume of 50--100 #1 PBS at 37~  for various times 
before removal  of unbound DSPG. The wells  were washed  with 
PBS containing 0.1% Tween 20 and the amount of  bound DSPG was 
determined by breaking off the individual  wells of the Immulon 2 
removawell  plate and counting them in an LKB gamma counter. 
Results  are expressed as the means and ranges of determinations 
from at least  three wells. 
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Figure 5. Inhibition of 125I-DSPG  I and 125I-DSPG  II binding to in- 
tact fibronectin  (A and C) or the 105-kD fibronectin  fragment (B 
and D) by unlabeled  DSPG or its components. Fibronectin or 105- 
kD fibronectin  fragment-coated substrates  were blocked with 1% 
BSA, and preincubated with 50 #g/ml of intact DSPG I or DSPG 
II, isolated protein core from DSPG I or DSPG I/, or protein-free 
dermatan  sulfate  chains from DSPG I  or DSPG II for 60 min. 
50,000 cpm of iodinated  DSPG I or DSPG II was then added and 
allowed to incubate for 3 h at 37~  Unbound DSPG was removed 
followed by three washes with PBS containing 0.1% Tween 20. The 
wells were separated  and then counted individually  to quantify the 
bound material.  Results are expressed  as the means and ranges of 
determinations from at least  three wells. 
DSPG I  was used as a  ligand,  only small differences were 
observed between the amounts bound to wells coated with 
intact fibronectin, the  105-kD fibronectin fragment or BSA 
alone (Fig.  4  A). 
It is noteworthy that the 105-kD fibronectin fragment is a 
potent binder of the DSPGs despite the fact that this segment 
of  the  fibronectin  molecule  does  not  contain  a  known 
glycosaminoglycan binding site.  This prompted us to locate 
the fibronectin binding portion of the DSPG molecule. Wells 
coated with intact fibronectin or the 105-kD fibronectin frag- 
ment were  incubated  with  ~2~I-DSPG I  or  ~25I-DSPG II in 
the presence of unlabeled DSPG, isolated dermatan sulfate 
chains from DSPG I or DSPG II, or DSPG I or DSPG II core 
protein depleted of glycosaminoglycan chains. The results of 
these experiments  showed (Fig.  5) that binding of radiola- 
beled DSPG to intact fibronectin or the  105-kD fibronectin 
fragment was inhibited by both intact proteoglycan and the 
isolated protein core. Isolated dermatan sulfate chains only 
marginally affected the binding of DSPG I or DSPG II to ei- 
ther fibronectin substrate. 
These data  suggest that the binding  of DSPGs to intact 
fibronectin or the 105-kD fibronectin fragment is primarily 
mediated by the core protein. In fact, we could demonstrate 
a  direct  binding  of 125I-labeled  DSPG  II  core  protein  to 
these substrates in a time-dependent and reversible reaction 
(data not shown).  When increasing amounts of ~2~I-labeled 
DSPG  II or its  isolated  core protein  were added to wells 
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Figure 6.  The saturability  of 
binding of 125I-DSPG  II or its 
core  protein  to  substrates 
composed of either fibronec- 
tin  or  the  105-kD  fragment 
of fibronectin.  Immulon 2 mi- 
crotiter  removawells,  coated 
with  fibronectin  (A,  *),  the 
105-kD  fibronectin  fragment 
(B, e), or 1% BSA (A and B, 
I),  were  blocked  with  1% 
BSA for 60 min and incubated 
with  t2SI-DSPG II (A and B; 
specific  activity  =  150,000 
cpm/#g) or z25I-DSPG  II core 
protein (data not shown; spe- 
cific activity  =  101,500 cpm 
#g)  at  concentrations  from 
0-10 #g/well in 0.2 ml of PBS 
containing  1%  BSA.  After a 
3-h  incubation  at  37~  the 
wells  were  washed,  and  the 
amount of bound radioactiv- 
ity  was  determined.  Specifi- 
cally bound DSPG II (A and 
B,  A---A) was  calculated  as 
the amount bound to fibronec- 
tin  or  the  105-kD  fibronec- 
tin fragment minus that which 
bound to BSA-coated wells. In 
C-F, the data are plotted  ac- 
cording to the methodology of 
Scatchard  (31). (C) DSPG II 
binding  to  fibronectin,  (D) 
DSPG II binding to the 105- 
kD fibronectin  fragment; (E) 
DSPG II core protein binding 
to fibronectin;  and (F) DSPG 
II core protein binding to the 
105-kD fibronectin  fragment. 
The results  are expressed  as 
the  means  of determinations 
from  quadruplicate  wells. 
Bars  represent  the  standard 
deviation  of 12~I-labeled pro- 
tein bound. 
coated with fibronectin or the 105-kD fibronectin fragment, 
the amount of labeled ligand bound increased (Fig. 6, A and 
B).  By analyzing the amounts of ligand specifically bound 
to  the  adsorbed  fibronectins,  saturable  binding  could  be 
demonstrated.  Assuming molecular masses of 100 kD for 
DSPG II and 43 kD for the DSPG II core protein, the analy- 
ses of these binding data were performed according to the 
methodology of Scatchard  (31)  and  dissociation  constants 
were calculated. The binding of intact DSPG II to fibronec- 
tin or the  105-kD fibronectin  fragment appears  to involve 
one binding site with calculated dissociation constants of 3 
x  10  -7 M  (Fig. 6  C) and 1.5  x  10  -7 M  (Fig. 6 D), respec- 
tively. Analysis of the binding data for the 12SI-labeled core 
protein revealed two classes of binding sites in wells coated 
with  either  fibronectin  or  the  105-kD  fragment  of fibro- 
nectin with dissociation constants of 1.3  x  10-  ~ M  and  1.7 
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Cell Attachment 
Relative 
Substrate  Preincubation  Cells bound  cells bound 
%  % 
105  kD  -  56.3  100 
BSA  -  27.3  0 
131.4 
105  kD  CORE  I  (CI)  65.4 
119.7 
CORE  II (CII)  62.0  100  GAG I (GI)  56.3  104.5  GAG II (GII)  57.6 
17.2  105 kD  DSPG I  32.3  89.7  CI +  DSPG I  53.3  29.3  CII +  DSPG I  35.8  -27.3  GI +  DSPG I  19.4  -10.3  GII +  DSPG I  24.3 
6.9  105 kD  DSPG II  29.3  106.5  CI +  DSPG II  58.2  82.1  CII +  DSPG II  51.1  1.4  GI +  DSPG II  27.7  -7.2  GII +  DSPG II  25.2 
The effects of DSPG I, DSPG II, and their domains on cell attachment to sub- 
strates composed of the  105-kD fibronectin fragment.  Before seeding of the 
labeled CliO cells, substrates were preincubated with 100/tg/ml of intact pro- 
teoglycan, isolated protein core, isolated dermatan sulfate chains, or combina- 
tions in the order indicated. The  first preincubation was performed  with 50 
/zg/ml of test substance for 1 h and the second with 100/~g/ml for 1 h.  Subse- 
quently, cells were seeded, incubated for 90 min, and unbound and bound cells 
were removed and counted.  The number of cells attached to substrates com- 
posed of the 105-kD fibronectin fragment in the absence of any preincubation 
was set at 100%. The number of cells attached to BSA-coated wells was used 
as a negative control and was set at 0% (the actual percent difference divided 
by 0.29 =  the relative percent difference). For further details see Materials and 
Methods. 
hibited the binding of 12SI-DSPG to fibronectin-coated sub- 
strates, our data suggest that inhibition of cell attachment in- 
volves the binding of the core proteins to a domain(s) in the 
105-kD fibronectin fragment. However, binding of the pro- 
tein cores to the substrate does not appear to be sufficient 
to inhibit cell attachment.  In addition,  glycosaminoglycan 
chains need to be covalently attached to the core protein, as 
in the intact proteoglycan,  for biological activity to occur. 
Small Glycosaminoglycan Containing Proteoglycans 
Inhibit Cell Attachment 
A  number  of DSPG-related  proteoglycans  from  different 
sources were also tested for their ability to inhibit the attach- 
ment of CHO cells to fibronectin coated surfaces (Fig.  7). 
None of the proteoglycans tested affected the attachment of 
cells to substrates of intact fibronectin.  However, the gluc- 
uronic acid rich, cartilage PG-S1, the iduronic acid rich, ten- 
don PG-S2, and the scleral DSPG II effectively inhibited the 
attachment of CHO-K1 cells to substrates composed of the 
105-kD fibronectin fragment down to levels obtained with 
articular cartilage DSPG I  and DSPG II. These proteogly- 
cans all have core proteins  similar or identical to those of 
DSPG I or DSPG II but the composition of their glycosami- 
noglycan side chains varies. PG-S1 contains chondroitin sul- 
fate chains with few if any iduronic acids residues whereas 
in the tendon PG-S2, >70%  of the uronic acid residues are 
iduronic acid. In contrast to the effects seen with the DSPGs, 
the large cartilage CSPG and 59-kD fibromodulin proteogly- 
can were  unable  to  inhibit  cell  attachment  to the  105-kD 
fibronectin fragment at concentrations tested. 
x  10  -s M  for wells coated with fibronectin (Fig.  6 E) and 
8  x  10  -7 M  and 2.1  x  10  -8 M  on substrates  composed of 
the  105-kD fibronectin fragment (Fig.  6  F). 
Intact Proteoglycans Are Required for 
Biological Activity 
In attempts to identify the portion(s) of the DSPG responsi- 
ble for its ability to inhibit the attachment of CHO cells to 
substrates  composed of the  105-kD  fibronectin  fragment, 
cells  were  seeded  on  substrates  preincubated  with  intact 
DSPGs,  isolated protein core derived from the DSPGs,  or 
protein free glycosaminoglycan chains.  The results of these 
experiments (Table II) showed that only intact proteoglycans 
were able to inhibit cell attachment.  Preincubation of sub- 
strates with isolated protein core or glycosaminoglycan side 
chains had no inhibitory effect on cell attachment.  Hence, 
the intact form of  the DSPG is necessary for inhibition of  cell 
attachment.  However,  when  substrates  were  preincubated 
with the corresponding isolated protein core followed by an 
incubation with intact proteoglycans, the inhibitory activity 
of DSPG on cell attachment was neutralized.  The isolated 
core protein of DSPG I was effective in neutralizing the in- 
hibitory effects of both DSPG I  and DSPG II, whereas the 
isolated protein core of DSPG II effectively neutralized the 
effect of DSPG II but only marginally reduced the inhibitory 
effect of DSPG I. Isolated glycosaminoglycan chains did not 
affect the biological activity of the intact proteoglycan. Since 
the core protein,  but not the glycosaminoglycan chains,  in- 
Figure 7. The effects of various proteoglycans on cell attachment. 
Substrates  were coated with fibronectin  ([]) or the  105-kD  fibro- 
nectin fragment (ea) and the cell attachment assays were performed 
as previously described. Before the seeding of labeled  CHO ceils, 
substrates  were incubated with 100 ~g/ml of articular DSPG I, ar- 
ticular  DSPG II, PG-S1, PG-S2, scleral DSPG, fibromodulin  (59- 
kD), or the large cartilage  CSPG for I h. The cells were allowed 
to attach for 90 rain.  Unbound cells and bound cells were removed 
and counted as previously described and the percentage of cells 
bound was determined.  (i) A background level of cell binding to 
a substrate coated with BSA. The results are expressed as the means 
and ranges  of determinations  from at least two wefts. 
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In  this  study,  we  report that  small  galactosaminoglycan- 
containing proteoglycans modulate cell adhesion to fibro- 
nectin-coated substrates. In contrast to the results described 
by Lewandowska et al. (22) and recently by Winnemoller et 
al. (36), we find that the DSPGs do not interfere with the at- 
tachment of cells to substrates composed of intact fibronec- 
tin, but that they inhibit the attachment of cells to substrates 
composed of the 105-kD fibronectin cell-binding fragment. 
This discrepancy may be due to variations in techniques used 
and the differences in cell types assayed. 
The effects of the small DSPGs on cell adhesion also differ 
from those of  the large, rat yolk sac tumor chondroitin sulfate 
proteoglycan which inhibit the attachment of rat yolk sac tu- 
mor cells to fibronectin coated substrates (3). In this case, 
the proteoglycan seems to bind to one of the glycosamino- 
glycan binding sites in the fibronectin molecule, and through 
its bulkiness, interfere with cell attachment (3). In contrast, 
in our system, 100 #g/ml of  the large chondroitin sulfate pro- 
teoglycan from cartilage did not significantly affect CHO cell 
attachment to either intact fibronectin or the 105-kD fibro- 
nectin fragment-coated substrate. In comparison, the small 
DSPGs  showed significant inhibition of CHO cell attach- 
ment at concentrations as low as  10 #g/ml. 
Yamaguchi and Ruoslahti  (39)  have reported that CHO 
cells overexpressing the core protein of DSPG II showed en- 
hanced cell spreading and dramatic changes in growth prop- 
erties.  These data  were interpreted to  indicate a  role for 
DSPG II in the cell spreading and growth processes. Later 
results suggested that the observed effects were mediated at 
least in part by transforming growth factor-/3 (40) and were 
not a direct effect of a DSPG II interaction with the substrate 
molecules. In the present study, addition of exogenous DSPG 
I or DSPG II to a fibronectin substrate did not enhance the 
number of cells spread or the mean area of spread cells. In- 
stead, the DSPGs were found to impair the ability of cells 
to form focal adhesions. The extent by which added DSPG 
reduced focal adhesion formation on fibronectin-coated sub- 
strates was similar to that observed in experiments in which 
thrombospondin was added to endothelial cells attaching to 
fibronectin substrates  (25).  However, DSPGs only margi- 
nally affected the organization of the actin-containing stress 
fibers as compared with the extensive F-actin redistribution 
seen  in  thrombospondin-sensitive cells.  The presence  of 
F-actin microfilaments in the absence of vinculin-containing 
plaques is consistent with the observation that vinculin does 
not accumulate until the later stages of adhesion plaque for- 
mation (9). In contrast, while the process of focal adhesion 
formation is apparently sensitive to the presence of DSPGs, 
the stability of these structures is  not affected by DSPGs 
since the addition of DSPGs to spread endothelial cells grown 
in serum with existing focal adhesions did not affect the num- 
ber  or distribution  of these  adhesion  structures,  whereas 
thrombospondin caused  a  partial  loss  of preformed focal 
adhesions (25 and data not shown). 
The effects of the small DSPGs on cell adhesion appear to 
require the binding of the proteoglycan to fibronectin mole- 
cules or its fragments in the substrate.  Preliminary experi- 
ments showed that addition of DSPG I or DSPG II did not 
cause any displacement of either radiolabeled fibronectin or 
the 105-kD fibronectin fragment from the surface of the tis- 
sue culture plastic (data not shown). The interaction between 
the DSPGs and fibronectin involves the core proteins of the 
proteoglycans and domain(s) in the central segment of the 
fibronectin molecule encompassed by the 105-kD fragment. 
A  direct  binding  of  '25I-labeled  DSPGs  to  fibronectin- 
coated substrates was demonstrated. This interaction was in- 
hibited by isolated core proteins, but not by glycosaminogly- 
can chains.  However,  some apparently unrelated proteins 
such as casein and nonimmune IgG also inhibited the bind- 
ing  of  ~25I-DSPGs to  fibronectin  whereas  other  proteins 
such as ovalbumin, albumin, and fibrinogen were without 
effect at concentrations of 100 #g/ml (data not shown). Anal- 
ysis of the binding data suggests one class of binding sites 
on the fibronectins for intact DSPG II with a moderately high 
dissociation constant.  Binding  of isolated protein core to 
both the 105-kD fibronectin fragment and intact fibronectin 
demonstrated two classes of binding sites for the protein core 
ligand, each with markedly different calculated dissociation 
constants. Schmidt et al. (33) recently reported the presence 
of two classes of binding sites on intact fibronectin and the 
105-kD fibronectin fragment for both the core protein and 
the intact DSPG II. These differences in the number of bind- 
ing sites for intact DSPG II may explain some of the differ- 
ences observed between the two laboratories. 
Inhibition  of cell  adhesion  requires  a  binding  of the 
DSPGs to fibronectin in the substrate. However, addition of 
isolated core protein to a  substrate  composed of 105-kD 
fibronectin fragments is not sufficient to block cell attach- 
ment. For this biological activity, an intact proteoglycan is 
required.  Both DSPG I  and DSPG II seem to be equally 
effective. Although,  these  results  demonstrate the  impor- 
tance of the glycosaminoglycan chains for inhibition of cell 
attachment activity, the structural composition of the galac- 
tosaminoglycan chain does not appear to have a determining 
effect on the activity since DSPG II from tendon with an 
iduronic-rich glycosaminoglycan  chain was as effective in in- 
hibiting cell attachment as the bone-derived PG-S1 with its 
exclusively glucuronic acid containing glycosaminoglycan 
chains. It is possible that the role of the glycosaminoglycan 
chain is to provide enough bulk to sterically interfere with 
the binding of the appropriate integrin to the corresponding 
binding site in the fibronectin molecule. When intact fibro- 
nectin constitutes the substrate, it is possible that the glycos- 
aminoglycan  chains  interact  with  the  glycosaminoglycan 
binding sites of the fibronectin molecules and are effectively 
folded away from the appropriate binding site. Alternatively, 
cells may express receptors which interact with domains out- 
side the RGD site in the 105-kD fibronectin fragment. Such 
additional cell binding sites in fibronectin have been demon- 
strated (11, 18,  19, 23). 
The  current  study  suggests  that  DSPGs  are  potential 
modulators  of cell  adhesion  to  substrates  composed  of 
fibronectin or certain fragments of fibronectin. It also demon- 
strates the presence of a possible proteoglycan binding site 
on the fibronectin molecule and an interaction between the 
two which is mediated by protein-protein interactions rather 
than by ionic association with the glycosaminoglycan moiety 
of the proteoglycan. Previous studies of cells in vitro showed 
that fibronectin may bind to or become associated with a 
galactosaminoglycan containing molecule (14, 27). In addi- 
tion, recent studies have shown that a heparan sulfate pro- 
teoglycan, isolated from human lung fibroblasts, and related 
The Journal of Cell Biology, Volume  118, 1992  1530 to the species found in basement membranes, can bind with 
high affinity to fibronectin via its protein core (17). Obvi- 
ously, further studies are required to determine the physio- 
logical role of the proteoglycan-fibronectin interactions. 
We thank Drs. Dick Heinegard and Anders Malmstrom for providing gifts 
of the various proteoglycans. We also thank Ms. Stacey Schultz-Cherry for 
her assistance in cell  culturing. 
This investigation was supported by grants from the National Institutes 
of Health (AM27807 to M. Hook, HL44575 to J. E. Murphy-Ullrich, and 
AR34614  and AR21498 to L. C. Rosenberg). Funding was also received 
from the American Heart Association (880877  to J.  E.  Murphy-Ullrich) 
with partial support from the Alabama Affiliate.  D. Bidanset  is a  Helen 
Keller Eye Research Foundation predoctoral fellow. 
Received  for publication 30 April  1992. 
References 
1. Albelda, S. M., and C. Buck. 1990. Integrins and other cell adhesion mole- 
cules.  FASEB (Fed.  Am.  Soc.  Exp.  Biol.) J.  4:2868-2880. 
2. Bidanset, D. J., C. Guidry,  L. C. Rosenberg, H. U. Choi, R. Timpl, and 
M. Hook.  1992. Binding of the proteoglycan decorin to collagen type VI. 
J.  Biol.  Chem.  267:5250-5256. 
3. Brennan, M. J., A. Oldberg, E. G. Hayman, and E. Ruoslahti. 1983. Effect 
ofa proteoglycan produced by rat tumor cells on their adhesion to fibro- 
nectin-collagen substrata.  Cancer Res.  43:4302-4307. 
4.  Buck, C. A., and A. F. Horwitz.  1987. Cell surface receptors for extracel- 
lular matrix molecules. Annu.  Rev.  Cell Biol.  3:179-205. 
5. Burridge, K., K. Fath, T. Kelly, G. Nuckolls, and C. Turner.  1988. Focal 
adhesions: transmembrane junctions between the extracellular matrix and 
the cytoskeleton.  J.  Biol.  Chem.  243:616-626. 
6. Choi, H. U., T. L. Johnson, S. Pal, L. H. Tang, L. Rosenberg, and P. J. 
Neame.  1989. Characterization  of the dermatan  sulfate proteoglycans, 
DS-PGI and DS-PGII,  from bovine articular cartilage and skin by octyl 
sepharose chromatography.  J.  Biol.  Chem.  264:2876-2884. 
7. Coster, L., and L. A. Fransson.  1981. Isolation and characterization of der- 
matan sulfate proteoglycans  from bovine sclera.  Biochem.  J.  193:143- 
153. 
8. Couchman, I. R., M. Hook, D. A. Rees, and R. Timpl.  1983. Adhesion, 
growth,  and matrix production  by fibroblasts on laminin substrates.  J. 
Cell Biol.  96:177-183. 
9.  DePasquale, J. A., and C. S. Izzard.  1991. Accumulation of talin in nodes 
at the edge of the lamellipodium and separate incorporation into adhesion 
plaques at focal contacts in fibroblasts. J.  Cell Biol.  113:1351-1359. 
10.  Engvail, E., and E. Ruoslahti.  1977. Binding of the soluble form of fibro- 
blast surface protein,  fibronectin,  to collagen.  Int.  J.  Cancer.  20:1-5. 
I 1. Guan,  J., and R. O. Hynes.  1990. Lymphoid cells recognize an alterna- 
tively spliced segment of fibronectin via the integrin receptor  [ct4, B1]. 
Cell. 60:53-61. 
12. Hausser, H., and H. Kresse. 199  I.  Binding of  heparin  and of  the  small  pro- 
teoglycan decorin to the same endocytosis receptor proteins leads to 
different  metabolic consequences. J. Cell Biol. 114:45-52. 
13. Hausser, H., W. Hoppe, U. Ranch, and H. Kresse. 1989.  Endocytosis of 
a small  dermatan sulfate  proteoglycan:  identification  of  binding proteins. 
Biochem.  J. 263:137-142. 
14. Hedman, K.,  S.  Johansson, T. Vartio,  L. Kjellen,  A. Vaheri,  and M. Hook. 
1982. Structure  of the pericellular  matrix: association  of heparan and 
chondroitin sulfates  with fibronectin-procollagen fibers. Cell. 28:663- 
671. 
15. Heinegard, D., A. Bjorne-Persson, L. Coster,  A. Franzen, S. Gardell,  A. 
Maimstrom, M. Paulsson, R. Sandfalk, and K. Vogel. 1985.  The core 
proteins  of  large  and small  interstitial  proteoglycans  from various  connec- 
tive  tissues  form distinct  subgroups. Biochem.  J. 230:181-194. 
16. Heinegard, D., T. Larsson, Y. Sommarin, A. Franzen, M. Panlsson,  and 
E. Hedbom. 1986.  Two novel matrix  proteins  isolated  from articular  car- 
tilage  show wide distributions  among connective  tissues.  J. Biol. Chem. 
261:13866-13872. 
17.  Heremans,  A.,  B.  De Cock,  J.  Cassiman,  H.  Van der  Berghe,  and G. 
David.  1990. The core protein of the matrix-associated heparan sulfate 
proteoglycan  binds to fibronectin. J.  Biol.  Chem.  265:8716-8724. 
18. Humphries,  M. J., S. K. Akiyama,  A. Komoriya,  K. Olden, and K. M. 
Yamada.  1986. Identification of an alternatively  spliced site in human 
plasma fibronectin that mediates cell type specific adhesion. J.  Cell Biol. 
103:2637-2647. 
19. Humphries,  M. J., A. Komoriya,  S. K. Akiyama,  K. Olden,  and K. M. 
Yamada.  1987. Identifcation  of two distinct regions of the type HI con- 
necting  segment of human plasma  fibronectin that  promote  cell type- 
specific adhesion. J.  Biol.  Chem.  262:6886-6892. 
20.  Hunter, W.  1978. Radioimmunoassay. In Handbook of Experimental Im- 
munology.  D.  M.  Weir,  editor.  Blackwell Scientific Publications,  Ox- 
ford.  14.1-14.40. 
21. Hynes, R. O.  1987. Integrins: a family of cell surface receptors.  Cell. 48: 
549-554. 
22.  Lewandowska,  K.,  H.  U.  Choi,  L.  C.  Rosenborg,  L.  Zardi,  and L.  A. 
Culp.  1987. Fibronectin-mediated  adhesion of fibroblasts: inhibition by 
a dermatan sulfate proteoglycan and evidence for a cryptic glycosamino- 
glycan-bioding domain. J.  Cell Biol.  105:1443-1454. 
23.  McCarthy, J. B., S. T. Hagen, and L. T. Furcht.  1986. Human fibronectin 
contains distinct adhesion- and motility-promoting domains for metastatic 
melanoma cells. J.  Cell Biol.  102:179-188. 
24. Miekka,  S. I., K. C. Ingrain, and D. Manache.  1982. Rapid methods for 
isolation of human plasma fibronectin.  Thromb.  Res.  27:1-14. 
25.  Murphy-Ullrich,  J. E., and M. Hook.  1989. Thrombospondin  modulates 
focal adhesions in endothelial cells. J.  Cell Biol.  109:1309-1319. 
26.  Murphy-Ullrich, J. E., V. A. Lightner, I. Ankhil, Y. Z. Yan, H. P. Erick- 
son, and M. Hook.  1991. Focal adhesion integrity is downregulated by 
the alternatively  spliced domain of human tenascin. J.  Cell Biol.  115: 
1127-1136. 
27.  Perkins, M. E., T. H. Ji, andR. O. Hynes. 1979. Cross-linking of fibronec- 
tin to sulfated proteoglycans  at the cell surface.  Cell.  16:941-952. 
28.  Rosenberg, L. C., H. U. Choi, L. H. Tang, T. L. Johnson, S. Pal, C. Web- 
bet, A. Reiner, and A. R. Poole. 1985. Isolation of dermatan sulfate pro- 
teoglycans from mature bovine articular cartilage. J.  Biol.  Chem.  260: 
6304-6313. 
29.  Ruoslahti,  E.  1988. Fibronectin  and its receptors.  Annu.  Rev.  Biochem. 
57:375-413. 
30.  Sage, H., R. B. Vernon, S. E. Funk, E. A. Everitt, and J. Angello.  1989. 
SPARC, a secreted protein associated with cellular proliferation,  inhibits 
cell spreading  in vitro  and exhibits Ca+2-dependent binding to the ex- 
tracellular  matrix.  J.  Cell Biol.  109:341-356. 
31.  Scatchard, G. 1949. The attraction of proteins for small molecules and ions. 
Ann.  NY Acad.  Sci.  51:660-672. 
32.  Schmidt, G., H. Robenek, B. Harrach, J. Glossl, V. Nolte, H. Hormann, 
H. Richter, and H. Kresse.  1987. Interaction of a small dermatan sulfate 
proteoglycan  from fibroblasts with fibronectin. J.  Cell Biol.  104:1683- 
1691. 
33.  Schmidt, G., H. Hausser, and H. Kresse. 1991. Interaction of the small pro- 
teoglycan decorin with fibronectin; involvement of the sequence NKISK 
of the core protein.  Biochem.  J.  280:411-414. 
34. Tang,  L.  H.,  L.  C.  Rosenberg,  H.  Reihanian,  A.  M.  Jamieson,  and J. 
Blackwell.  1989. Proteoglycans  from  bovine  epiphyseai  cartilage. 
Sedimentation velocity and light scattering  studies of the effect of link 
protein  on proteoglycan  size  and  stability.  Connect.  Tissue  Res.  19: 
177-193. 
35. Vogel, K. G., and D. Heinegard.  1985. Characterization of proteoglycans 
from adult bovine tendon. J.  Biol.  Chem.  260:9298-9306. 
36. Winnemoller, M., G. Schmidt, and H. Kresse.  1991. Influence of decorin 
on fibroblast adhesion to fibronectin. Eur.  J.  Cell Biol.  54:10-17. 
37. Woods,  A., and J. R. Couchman.  1988. Focal adhesions and cell matrix 
interactions.  Collagen  Relat.  Res.  8:155-182. 
38. Woods, A., J. R. Couchman, S. Johansson, and M. Hook.  1986. Adhesion 
and cytoskeletal  organization  of fibroblasts  in response  to  fibronectin 
fragments.  EMBO (Eur.  Mol.  Biol.  Organ.) J.  5:665-670. 
39.  Yamaguchi, Y., and E. Ruoslahti.  1988. Expression of human proteogly- 
can  in Chinese  hamster  ovary  cells  inhibits  cell  proliferation.  Nature 
(Lond.). 336:244-246. 
40.  Yamaguchi, Y., D. M. Mann, and E. Ruoslahti.  1990. Negative regulation 
of transforming  growth factor-B by  the  proteoglycan  decorin.  Nature 
(Lond.). 346:281-284. 
Bidanset et al. Dermamn Sulfate Proteoglycans and Cell Adhesion  1531 